Go to Polygence Scholars page
Plara Paik's cover illustration
Polygence Scholar2023
Plara Paik's profile

Plara Paik

Class of 2025Oak Park, California

About

Projects

  • "How does the use of Perphenazine and Thiothixene differ amongst adolescent Schizophrenia patients?" with mentor Laura (Sept. 24, 2023)

Project Portfolio

How does the use of Perphenazine and Thiothixene differ amongst adolescent Schizophrenia patients?

Started Apr. 21, 2023

Abstract or project description

Schizophrenia is a chronic and severe psychiatric disorder that commonly manifests during adolescence. Antipsychotic medications play a vital role in managing the symptoms and improving the quality of life for adolescent patients with schizophrenia. Perphenazine and Thiothixene are two typical antipsychotics that have been used in the treatment of schizophrenia. When considering the use of Perphenazine and Thiothixene in adolescent schizophrenic patients, clinicians must carefully assess the risks and benefits of treatment. Factors such as the severity of symptoms, individual patient characteristics, and potential side effects should be considered when making treatment decisions. Regular monitoring and dose adjustments are also necessary to ensure optimal outcomes and minimize side effects. While Perphenazine and Thiothixene have been used for decades in the treatment of schizophrenia, newer atypical antipsychotics have gained popularity due to their potentially lower risk of side effects and improved tolerability. Nonetheless, Perphenazine and Thiothixene can still be valuable treatment options for select adolescent schizophrenic patients, particularly when considering cost-effectiveness or lack of response to other medications. Future research is warranted to further evaluate their efficacy and safety profiles in this specific patient population, particularly in comparison to newer antipsychotic agents.